PATENT CLAIM ANALYSIS

Application Number: 15987277
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "210180"]

Abstract:
Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

Claim (Index 9):
A pharmaceutical composition, comprising a compound or pharmaceutically acceptable salt according to  claim 1  and one or more pharmaceutically acceptable carriers.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15388350', '14296730', '14895718', '14868516', '14296794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8087892049151484
- 35 USC 102 Novelty (BERT): 0.6115049697677825
- Combined Prediction Score: 0.7890607814004118
- Mean Citation Score: 514.875808
- Max Citation Score: 525.1804
- Similarity Product: 517.2315180560112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test